OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
|
HK |
|
Icade SA
PAR:ICAD
|
FR |
|
Redwoods Acquisition Corp
NASDAQ:WENA
|
US |
|
P
|
PayPal Holdings Inc
F:2PP
|
US |
|
Sosandar PLC
LSE:SOS
|
UK |
|
Interpace Biosciences Inc
OTC:IDXG
|
US |
Wall Street
Price Targets
Price Targets Summary
OrbusNeich Medical Group Holdings Ltd
According to Wall Street analysts, the average 1-year price target for OrbusNeich Medical Group Holdings Ltd is 5.66 HKD with a low forecast of 5.35 HKD and a high forecast of 6.09 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is OrbusNeich Medical Group Holdings Ltd's stock price target?
Price Target
5.66
HKD
According to Wall Street analysts, the average 1-year price target for OrbusNeich Medical Group Holdings Ltd is 5.66 HKD with a low forecast of 5.35 HKD and a high forecast of 6.09 HKD.
What is OrbusNeich Medical Group Holdings Ltd's Revenue forecast?
Projected CAGR
7%
For the last 4 years the compound annual growth rate for OrbusNeich Medical Group Holdings Ltd's revenue is 12%. The projected CAGR for the next 2 years is 7%.
What is OrbusNeich Medical Group Holdings Ltd's Operating Income forecast?
Projected CAGR
5%
For the last 4 years the compound annual growth rate for OrbusNeich Medical Group Holdings Ltd's operating income is 19%. The projected CAGR for the next 3 years is 5%.
What is OrbusNeich Medical Group Holdings Ltd's Net Income forecast?
Projected CAGR
37%
The compound annual growth rate of OrbusNeich Medical Group Holdings Ltd's net income for the next 2 years is 37%.
